Bayer today announced that its MEDRAD® Centargo multi-patient CT injector has secured 510(k) clearance from the U.S. Food and Drug Administration (FDA) to expand the use of compatible contrast agent ...
Iodine-based contrast material injected intravenously to enhance CT images can be safely used in most patients, according to a study. Of the 80 million or more CT scans performed each year in the ...
It is commonplace for patients with Acute Lung Injury (ALI) to be injected with a dye, known as contrast material, before undergoing a CT (computerized tomography) scan of their lungs. Contrast ...
A CT scan of the abdomen can show the organs, blood vessels, and bones in your abdominal cavity. The multiple images provided by the scan can give your doctor many different views of your body. A CT ...
The contrast media injectors market shall expand at a CAGR of 4.9% through 2030, but gains in 2020 will be impacted by the sluggishness induced by COVID-19. Future Market Insights, in its new study, ...
Follows recent FDA clearance to expand the use of compatible contrast agent presentations, adding single-dose vials in addition to Imaging Bulk Package presentations Radiology suites now have the ...
Centargo compatible with Ultravist® (iopromide), Isovue® (iopamidol), Optiray® (ioversol), Omnipaque™ (iohexol) and now, Visipaque™ (iodixanol) Follows recent FDA clearance to expand the use of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results